PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--ForteBio, a division of Pall Life Sciences and a leading supplier of instrumentation for accelerated drug discovery and development, today announced the launch ...
Pall ForteBio LLC, a division of Pall Corp. and a leading supplier of instrumentation and analytics for accelerated drug discovery and development, has announced commercial availability of a new Dip ...
ForteBio’s Dip and Read Method Simplifies Label-Free Assays Molecular interactions play a myriad of important roles in drug discovery and development. From determining mechanism of action to ...